These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33991474)

  • 21. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    Barda N; Dagan N; Balicer RD
    N Engl J Med; 2021 May; 384(20):1970. PubMed ID: 33882227
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Jun; 397(10291):2249-2250. PubMed ID: 34119061
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to "PEG skin testing for COVID-19 allergy".
    Banerji A; Phillips E; Saff R; Wickner PG; Robinson LB; Wolfson AR; Williams P; Khan DA; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765-1766. PubMed ID: 33838846
    [No Abstract]   [Full Text] [Related]  

  • 24. Mandatory Coronavirus Disease 2019 Vaccine for Children?-Reply.
    Opel DJ; Diekema DS; Ross LF
    JAMA Pediatr; 2021 May; 175(5):534. PubMed ID: 33555288
    [No Abstract]   [Full Text] [Related]  

  • 25. Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.
    Tumban E
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply: Coronavirus disease 2019 vaccines in pregnancy.
    Craig AM; Hughes BL; Swamy GK
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100337. PubMed ID: 33621715
    [No Abstract]   [Full Text] [Related]  

  • 27. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC29. PubMed ID: 33646835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection.
    Müller-Sedgwick U
    BMJ; 2021 Feb; 372():n522. PubMed ID: 33627357
    [No Abstract]   [Full Text] [Related]  

  • 29. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 vaccination in our transplant recipients: The time is now.
    Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
    J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.
    Xu W; Su S; Jiang S
    Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2 Vaccines.
    Creech CB; Walker SC; Samuels RJ
    JAMA; 2021 Apr; 325(13):1318-1320. PubMed ID: 33635317
    [No Abstract]   [Full Text] [Related]  

  • 33. Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution.
    Chen F; Gong S; Li RQ
    J Epidemiol; 2020 Dec; 30(12):574-575. PubMed ID: 33041320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Development and use of vaccines from the 18th century to the SARS-CoV 2 period].
    Skinhøj P; Bygbjerg IC
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biosecurity of COVID-19 vaccines.
    Kantor IN
    Medicina (B Aires); 2020; 80 Suppl 6():104-106. PubMed ID: 33481741
    [No Abstract]   [Full Text] [Related]  

  • 38. Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
    Maykin MM; Heuser C; Feltovich H;
    Vaccine; 2021 Jan; 39(2):171-172. PubMed ID: 33308888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?-Authors' reply.
    Lanza GA; De Vita A
    Europace; 2021 Jul; 23(7):1151. PubMed ID: 34077534
    [No Abstract]   [Full Text] [Related]  

  • 40. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.